Answers are grounded in this paper and cite their sources.
Accurate classification of cell death pathways is critical in understanding disease mechanisms and evaluating therapeutic responses, as dysregulated cell death underlies a wide range of pathological conditions including cancer and therapy resistance. Conventional imaging methods such as fluorescence and bright-field microscopy, or 2D phase imaging, often suffer from phototoxicity, labeling artifacts, or limited morphological contrast. Here, we present a real-time, label-free platform for classifying cell death phenotypes—apoptosis, necroptosis, and necrosis—by combining three-dimensional holotomography with deep learning. Our convolutional neural network, trained on refractive index (RI)-based features from HeLa cells, achieved high classification accuracy (97.2 ± 2.8%) under varying cell densities. Notably, the model identified early RI changes during necroptosis several hours prior to fluorescence-based markers. These findings demonstrate the potential of holotomography-based AI for high-resolution, label-free cell death profiling.
No takes yet. Share an insight, caveat, or question.
Park et al. (2025) studied this question.
Synapse has enriched 8 closely related papers on similar clinical questions. Consider them for comparative context: